Follicular hybrid cyst
| Follicular hybrid cyst | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Skin cyst, nodule |
| Complications | |
| Onset | |
| Duration | |
| Types | N/A |
| Causes | |
| Risks | |
| Diagnosis | Histopathology |
| Differential diagnosis | Epidermoid cyst, Pilar cyst |
| Prevention | |
| Treatment | Surgical excision |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | N/A |
Follicular hybrid cyst is a dermatological condition characterized by the formation of a cyst that exhibits features of both epidermoid cysts and trichilemmal cysts. These cysts are considered rare and present a unique challenge in diagnosis and treatment due to their hybrid nature. The understanding of follicular hybrid cysts is crucial for dermatologists and pathologists in order to provide accurate diagnosis and appropriate management.
Etiology[edit]
The exact cause of follicular hybrid cysts remains unclear. However, it is believed that these cysts arise due to the aberrant differentiation of the follicular epithelium. Factors that may contribute to the development of follicular hybrid cysts include genetic predispositions, hormonal influences, and local trauma. The hybrid nature suggests a complex interplay between the pathways leading to the development of epidermoid and trichilemmal cysts.
Pathophysiology[edit]
Follicular hybrid cysts are characterized by their unique histological features. Microscopically, these cysts show areas resembling both epidermoid cysts, which are lined by stratified squamous epithelium with a granular layer, and trichilemmal cysts, which are lined by stratified squamous epithelium without a granular layer and have a compact keratin content. The presence of these two distinct types of epithelial lining within the same cyst is the hallmark of follicular hybrid cysts.
Clinical Presentation[edit]
Patients with follicular hybrid cysts typically present with a solitary, asymptomatic, and slow-growing nodule. The cysts are most commonly located on the scalp, face, neck, or trunk. Occasionally, the cysts may become inflamed or infected, leading to pain and erythema.
Diagnosis[edit]
The diagnosis of a follicular hybrid cyst is primarily based on histopathological examination. Imaging studies such as ultrasound or MRI may be used to assess the cyst's size, depth, and relationship with surrounding structures but are not diagnostic. Fine-needle aspiration (FNA) biopsy is not typically recommended due to its low diagnostic yield for cystic lesions.
Treatment[edit]
The standard treatment for follicular hybrid cysts is complete surgical excision. This approach minimizes the risk of recurrence and allows for definitive histopathological examination. In cases where the cyst is inflamed or infected, initial management may include antibiotics or incision and drainage, followed by elective excision once inflammation has subsided.
Prognosis[edit]
The prognosis for patients with follicular hybrid cysts is generally excellent, with complete excision typically resulting in a cure. Recurrence is rare but may occur if the cyst is not completely removed.
Conclusion[edit]
Follicular hybrid cysts represent a unique and rare entity within the spectrum of cutaneous cysts. Due to their hybrid features, they pose a diagnostic challenge and require careful histopathological examination. Complete surgical excision is the treatment of choice, offering an excellent prognosis for affected patients.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian